| 000 | 01548 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513132035.0 | ||
| 264 | 0 | _c19980206 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a1387-2273 | ||
| 024 | 7 |
_a10.1016/s0378-4347(97)00243-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDePuy, M E | |
| 245 | 0 | 0 |
_aStereoselective determination of R-(+)- and S-(-)-remoxipride, a dopamine D2-receptor antagonist, in human plasma by chiral high-performance liquid chromatography. _h[electronic resource] |
| 260 |
_bJournal of chromatography. B, Biomedical sciences and applications _cOct 1997 |
||
| 300 |
_a165-73 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aCapsules |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDopamine Antagonists _xblood |
| 650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aRemoxipride _xblood |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aDemetriades, J L | |
| 700 | 1 | _aMusson, D G | |
| 700 | 1 | _aRogers, J D | |
| 773 | 0 |
_tJournal of chromatography. B, Biomedical sciences and applications _gvol. 700 _gno. 1-2 _gp. 165-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0378-4347(97)00243-0 _zAvailable from publisher's website |
| 999 |
_c9360483 _d9360483 |
||